Glycoprotein B (EBV)

Glycoprotein B (EBV) Informations sur la molécule

Nom anglais	Envelope glycoprotein B, gB	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2	Alias de la cible	UL55
Phase de R&D la plus avancée	Phase 2 Clinical

Nom anglais	Envelope glycoprotein B, gB
Alias de la cible	UL55
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2
Phase de R&D la plus avancée	Phase 2 Clinical

Demande de produit

Glycoprotein B (EBV)Contexte de la molécule

Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research.

Glycoprotein B (EBV)Alias de la molécule

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
Fiztasovimab	NPC-21	Phase 2 Clinical	Nobelpharma Co Ltd	Cytomegalovirus Infections	Details
TRL-345	CMV-345; TRL-345	Phase 1 Clinical	Trellis Bioscience LLC	Cytomegalovirus Infections	Details